logo

For the Inventor, By the Inventor

Berlin, Germany

Gerhard Kossmehl

This inventor holds 14 USPTO granted patents. Top assignees: Ciba-Geigy Corporation, Bayer Aktiengesellschaft, Basf Aktiengesellschaft. Active years: 1982-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerhard Kossmehl. Retrieved from https://idiyas.com/inventor/gerhard-kossmehl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14

% Patents Active = 92.9

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 193(Granted Patents)


Location History:

  • Berlin-Lichterfelde, DE (1992 - 1993)
  • Berlin, DE (1982 - 2002)

Company Filing History:

goldMedal4 out of 6,858 
 
Ciba-Geigy Corporation
 patents
silverMedal3 out of 12,269 
 
Bayer Aktiengesellschaft
 patents
bronzeMedal2 out of 10,816 
 
Basf Aktiengesellschaft
 patents
4. 1 out of 630 
 
Dainippon Ink and Chemicals, Incorporated
 patents
5. 1 out of 997 
 
Man Roland Druckmaschinen Ag
 patents
6. 1 out of 24 
 
Man Technologie Gmbh
 patents
7. 1 out of 1 
 
Titmus Eurocon
 patent
8. 1 out of 834,601 
Other
 patents

Years Active: 1982-2002

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6500222 - Diureides and their use (2002-12-31),
2. 6353134 - Diureides and their use (2002-03-05),
3. 5488093 - Stiff-chain polyesters and a method of preparing them (1996-01-30),
4. 5214452 - Hydrogels based on fluorine-containing and saccharide monomers (1993-05-25),
5. 5155194 - Hydrogels based on fluorine-containing and saccharide monomers (1992-10-13),
6. 5145758 - Method of producing a printing image carrier (1992-09-08),
7. 4920184 - Hydrophilic silicone rubber article and process for its preparation (1990-04-24),
8. 4872962 - Printing press (1989-10-10),
9. 4853453 - Modified silicone rubber and its use as a material for optical lenses (1989-08-01),
10. 4849520 - Fusible, electrically conductive TCNQ complexes, methods for their (1989-07-18),
11. 4617143 - Oxidizing polymerization with AsF.sub.5 (1986-10-14),
12. 4611032 - Oxidizing polymerization with NO.sup..sym. and NO.sub.2.sup..crclbar. (1986-09-09),
13. 4490509 - Poly-(2,5-thiophendiyl)arsenic pentafluoride complexes (1984-12-25),
14. 4332922 - Process for rendering silicone rubber contact lenses hydrophilic (1982-06-01),

Title: The Innovative Journey of Gerhard Kossmehl

Introduction: Gerhard Kossmehl, based in Berlin, Germany, is a distinguished inventor known for his significant contributions in the field of pharmaceuticals, particularly in the development of diureides. With a remarkable portfolio of 14 patents, he has made a lasting impact on medical research and drug development.

Latest Patents: Among his most notable recent patents is "Diureides and their use." This groundbreaking work exemplifies Kossmehl's commitment to advancing medical science and providing innovative solutions to health-related challenges.

Career Highlights: Kossmehl has had a prolific career, working with renowned companies such as Ciba-Geigy Corporation and Bayer Aktiengesellschaft. His tenure at these respected organizations allowed him to develop and refine his expertise in drug formulation and pharmacology.

Collaborations: Throughout his career, Kossmehl has collaborated with other prominent experts in the field, including Horst Schafer and Detlef Kabbeck-Kupijai. These partnerships have contributed to the successful development of innovative pharmaceutical products and technologies.

Conclusion: Gerhard Kossmehl's legacy as an inventor is marked by his dedication to innovation and excellence. With 14 patents to his name and a history of collaboration with industry leaders, Kossmehl continues to influence the landscape of pharmaceutical development and inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…